These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 27436156)
1. Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review. Liu LY; King BA; Craiglow BG J Am Acad Dermatol; 2016 Oct; 75(4):806-812.e3. PubMed ID: 27436156 [TBL] [Abstract][Full Text] [Related]
2. Alopecia areata and health-related quality of life: a systematic review and meta-analysis. Rencz F; Gulácsi L; Péntek M; Wikonkál N; Baji P; Brodszky V Br J Dermatol; 2016 Sep; 175(3):561-71. PubMed ID: 26914830 [TBL] [Abstract][Full Text] [Related]
3. Health-Related Quality of Life (HRQoL) in alopecia areata patients-a secondary analysis of the National Alopecia Areata Registry Data. Shi Q; Duvic M; Osei JS; Hordinsky MK; Norris DA; Price VH; Amos CI; Christiano AM; Mendoza TR J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S49-50. PubMed ID: 24326555 [TBL] [Abstract][Full Text] [Related]
4. HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety. Russo PM; Fino E; Mancini C; Mazzetti M; Starace M; Piraccini BM J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):608-611. PubMed ID: 30394586 [TBL] [Abstract][Full Text] [Related]
5. Impact of cyclosporin treatment on health-related quality of life of patients with alopecia areata. Lai VWY; Chen G; Sinclair R J Dermatolog Treat; 2021 Mar; 32(2):250-257. PubMed ID: 31389731 [TBL] [Abstract][Full Text] [Related]
6. Severity of disease and quality of life in parents of children with alopecia areata, totalis, and universalis: A prospective, cross-sectional study. Putterman E; Patel DP; Andrade G; Harfmann KL; Hogeling M; Cheng CE; Goh C; Rogers RS; Castelo-Soccio L J Am Acad Dermatol; 2019 May; 80(5):1389-1394. PubMed ID: 30633941 [TBL] [Abstract][Full Text] [Related]
7. Assessing quality of life in Alopecia areata patients in China. Qi S; Xu F; Sheng Y; Yang Q Psychol Health Med; 2015; 20(1):97-102. PubMed ID: 24628099 [TBL] [Abstract][Full Text] [Related]
8. Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study. Caldarola G; Raimondi G; Samela T; Pinto L; Pampaloni F; Starace MVR; Diluvio L; Dall'Oglio F; Vagnozzi E; de Felici Del Giudice MB; Balestri R; Ambrogio F; Girolomoni G; Riva SF; Moro F; Atzori L; Gallo G; Ribero S; Simonetti O; Barruscotti S; Boccaletti V; Marzano AV; Bianchi L; Micali G; Piraccini BM; Fargnoli MC; Abeni D; Peris K Front Public Health; 2024; 12():1415334. PubMed ID: 39220459 [TBL] [Abstract][Full Text] [Related]
9. Clinical profile and impact on quality of life: seven years experience with patients of alopecia areata. Al-Mutairi N; Eldin ON Indian J Dermatol Venereol Leprol; 2011; 77(4):489-93. PubMed ID: 21727697 [TBL] [Abstract][Full Text] [Related]
10. PUVA treatment of alopecia areata totalis and universalis: a retrospective study. Whitmont KJ; Cooper AJ Australas J Dermatol; 2003 May; 44(2):106-9. PubMed ID: 12752182 [TBL] [Abstract][Full Text] [Related]
11. Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients. Liu LY; Craiglow BG; Dai F; King BA J Am Acad Dermatol; 2017 Jan; 76(1):22-28. PubMed ID: 27816293 [TBL] [Abstract][Full Text] [Related]
12. Alopecia areata and overt thyroid diseases: A nationwide population-based study. Han TY; Lee JH; Noh TK; Choi MW; Yun JS; Lee KH; Bae JM J Dermatol; 2018 Dec; 45(12):1411-1417. PubMed ID: 30222206 [TBL] [Abstract][Full Text] [Related]
13. Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation. Glickman JW; Dubin C; Renert-Yuval Y; Dahabreh D; Kimmel GW; Auyeung K; Estrada YD; Singer G; Krueger JG; Pavel AB; Guttman-Yassky E J Am Acad Dermatol; 2021 Feb; 84(2):370-380. PubMed ID: 32376430 [TBL] [Abstract][Full Text] [Related]
14. Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata. Bilgiç Ö; Bilgiç A; Bahalı K; Bahali AG; Gürkan A; Yılmaz S J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1463-8. PubMed ID: 24237476 [TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life of adult and adolescent patients living with alopecia areata in Australia. Sinclair R; Eisman S; Lee CMY; Hitschfeld M; Witcombe D; Pereira CDF Australas J Dermatol; 2024 Aug; 65(5):451-461. PubMed ID: 38764404 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis. Lee HH; Gwillim E; Patel KR; Hua T; Rastogi S; Ibler E; Silverberg JI J Am Acad Dermatol; 2020 Mar; 82(3):675-682. PubMed ID: 31437543 [TBL] [Abstract][Full Text] [Related]
17. A case-control study on family dysfunction in patients with alopecia areata, psoriasis and atopic dermatitis. Poot F; Antoine E; Gravellier M; Hirtt J; Alfani S; Forchetti G; Linder D; Abeni D; Tabolli S; Sampogna F Acta Derm Venereol; 2011 Jun; 91(4):415-21. PubMed ID: 21336474 [TBL] [Abstract][Full Text] [Related]
19. Association of Vitiligo and Alopecia Areata With Atopic Dermatitis: A Systematic Review and Meta-analysis. Mohan GC; Silverberg JI JAMA Dermatol; 2015 May; 151(5):522-8. PubMed ID: 25471826 [TBL] [Abstract][Full Text] [Related]